Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Intervention3: Nil: Nil
Sponsors
NGSM Institute of Pharmaceutical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Patients are diagnosed with type 2 diabetes mellitus for at least 12 months. Age between 25 - 84 years. On medications for diabetes management. Patients are open to completing questionnaires and interviews to evaluate their quality of life. Patients are not receiving treatment for cardiovascular disease.
Exclusion criteria
Exclusion criteria: Patients who are diagnosed with type 1 diabetes mellitus or gestational diabetes. Patients with terminal illnesses. Patients with psychiatric illnesses. Patients with type 2 diabetes mellitus who had trauma-related amputations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Early prediction of CVD risk in type II diabetes mellitus patients will help prevent severe complications. Timepoint: 8 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate health-related quality of life in patients with type 2 diabetes mellitusTimepoint: 8 months;To estimate the association between cardiovascular disease risk scores and quality of life measures in patients with type 2 diabetes mellitusTimepoint: 8 momths | — |
Countries
India
Contacts
Public ContactDr Uday Venkat Mateti
NGSM Institute of Pharmaceutical Sciences
Outcome results
None listed